NorthStar Medical Radioisotopes has received and installed a specialized device that can produce a radioactive material used in certain cancer therapies.

The company recently announced the custom-built electron beam accelerator was delivered and installed at its Beloit facility, which will be dedicated to producing the therapeutic radioisotope called actinium-225.

According to a release from NorthStar, this substance is used in clinical studies for targeted radiopharmaceutical therapy, which can destroy cancerous cells with radiation while avoiding healthy cells. While Ac-225 is gaining popularity among medical experts for this type of therapy, current availability is “inadequate” for clinical trials, research and commercial application due to production limitations, the company says.

Click here to read the full article.